Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Cell Cancers of the Head and Neck × Afatinib × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 12 Head and Neck Neoplasms 10 Carcinoma, Squamous Cell 2 Squamous Cell Cancers of the Head and Neck 1 Neoplasms, Squamous Cell 1 Mouth Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Fanconi Anemia 1

Interventions

Cetuximab 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02979977 2026-02-04

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck

Yale University

Phase 2 Completed

50 enrolled 14 charts

Squamous Cell Cancers of the Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡